Sarcomeric dysfunction contributes to muscle weakness in facioscapulohumeral muscular dystrophy

Neurology

Volumn 80, Issue 8, 2013, Pages 733-737

  Lassche, Saskia ^a   Stienen, Ger J M ^b,c   Irving, Tom C ^d   Van Der Maarel, Silvère M ^e   Voermans, Nicol C ^a   Padberg, George W ^a   Granzier, Henk ^f   Van Engelen, Baziel G M ^a   Ottenheijm, Coen A C ^b,f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Illinois Institute of Technology   (United States)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BIOPSY; CASE REPORT; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MUSCLE CELL; MUSCLE WEAKNESS; MYOFILAMENT; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; SARCOMERE; SARCOMERE LENGTH; X RAY DIFFRACTION;

ADULT; ELECTROPHYSIOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MICROSCOPY, CONFOCAL; MUSCLE WEAKNESS; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; SARCOMERES; X-RAY DIFFRACTION;

EID: 84876210853     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318282513b     Document Type: Article

References (12)

1. Lemmers RJ, van der Vliet PJ, Klooster R, et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 2010;329:1650-1653.
2. Celegato B, Capitanio D, Pescatori M, et al. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 2006;6:5303-5321.
3. Wallace LM, Garwick SE, Mei W, et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann Neurol 2011;69:540-552.
4. Ottenheijm CA, Lawlor MW, Stienen GJ, Granzier H, Beggs AH. Changes in cross-bridge cycling underlie muscle weakness in patients with tropomyosin 3-based myopathy. Hum Mol Genet 2011;20:2015-2025.
5. Ottenheijm CA, Voermans NC, Hudson BD, et al. Titinbased stiffening of muscle fibers in Ehlers Danlos syndrome. J Appl Physiol 2012;112:1157-1165.
6. Granzier HL, Labeit S. The giant protein titin: a major player in myocardial mechanics, signaling, and disease. Circ Res 2004;94:284-295.
7. Rando TA. Oxidative stress and the pathogenesis of muscular dystrophies. Am J Phys Med Rehabil 2002;81:S175-S186.
8. Krivickas LS, Ansved T, Suh D, Frontera WR. Contractile properties of single muscle fibers in myotonic dystrophy. Muscle Nerve 2000;23:529-537.
9. Trappe S, Trappe T, Gallagher P, Harber M, Alkner B, Tesch P. Human single muscle fibre function with 84 day bed-rest and resistance exercise. J Physiol 2004;557:501-513.
10. Krivickas LS, Amato AA, Krishnan G, Murray AV, Frontera WR. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study. Neuromuscul Disord 2005;15:349-354.
11. Reed P, Porter NC, Strong J, et al. Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy. Ann Neurol 2006;59:289-297.
12. Ricci E, Galluzzi G, Deidda G, et al. Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol 1999; 45:751-757.